Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Effects of Sulforaphane for Patients With Chronic Kidney Disease [NA]

View source ↗

Summary

A clinical trial is evaluating the effects of sulforaphane in patients with chronic kidney disease. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Chronic Kidney Disease | NA | Status: ACTIVE_NOT_RECRUITING